Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development, commercialization, and manufacturing of novel therapeutics. The Company applies its expertise in antigen identification, engineering, and cell processing to produce autologous cellular immunotherapy (ACI) product candidates designed to stimulate an immune response in a variety of tumor types.